Lília Maia Santos

ORCID: 0000-0003-3215-4701
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Medication Adherence and Compliance
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Obstructive Sleep Apnea Research
  • Lung Cancer Diagnosis and Treatment
  • Mobile Health and mHealth Applications
  • Allergic Rhinitis and Sensitization
  • Inhalation and Respiratory Drug Delivery
  • Impact of Technology on Adolescents
  • Digital Mental Health Interventions
  • Tracheal and airway disorders
  • Voice and Speech Disorders
  • Pulmonary Hypertension Research and Treatments
  • Esophageal and GI Pathology
  • Head and Neck Cancer Studies
  • Respiratory and Cough-Related Research
  • Pleural and Pulmonary Diseases
  • Biocrusts and Microbial Ecology
  • Pediatric health and respiratory diseases
  • Esophageal Cancer Research and Treatment
  • Aquatic Ecosystems and Phytoplankton Dynamics
  • Gastric Cancer Management and Outcomes
  • Cystic Fibrosis Research Advances
  • Algal biology and biofuel production

Hospitais da Universidade de Coimbra
2016-2020

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2020

Instituto do Coração
2020

Hospital do Coração
2020

University of Coimbra
2019

We aimed to compare patient's and physician's ratings of inhaled medication adherence identify predictors patient-physician discordance. Baseline data from two prospective multicentre observational studies. 29 allergy, pulmonology paediatric secondary care outpatient clinics in Portugal. 395 patients (≥13 years old) with persistent asthma. Data on demographics, relationship, upper airway control, asthma treatment, forced expiratory volume one second (FEV1) healthcare use were collected....

10.1136/bmjopen-2019-031732 article EN cc-by-nc BMJ Open 2019-11-01

We evaluated the effect of weight loss (WL) on lung function (LF) in obese individuals who underwent bariatric surgery, and asthma control, quality life, LF, controller medication a sub-group (OA) patients. Obese surgery between July 2015 2017 were included this prospective longitudinal study. They classified as OA or non-asthmatics (O-NA). LF was assessed preoperatively 6–9 months postoperatively. In patients, treatment step evaluated. P < 0.05 considered significant. Twenty-six patients...

10.1016/j.pulmoe.2019.07.007 article EN cc-by-nc-nd Pulmonology 2019-09-14

Background: Poor medication adherence is a major challenge in asthma and objective assessment of inhaler needed. InspirerMundi app aims to monitor while turning it into positive experience through gamification social support. Objective: We assessed the medium-term feasibility real-world patients with persistent (treated daily inhaled medication). In addition, we attempted identify characteristics related higher use. Methods: Two multicenter observational studies, one initial face-to-face...

10.3389/fmedt.2021.649506 article EN cc-by Frontiers in Medical Technology 2021-07-15

A metabolite screening of cyanobacteria was performed by nuclear magnetic resonance (NMR) analysis the soluble material obtained through sequential extraction biomass with three different extractive ability solvents (hexane, ethyl acetate, and methanol). Twenty-five strains from Coimbra Collection Algae (ACOI) belonging to orders in botanical code that represent subsections Stainer-Rippka classification were used. The 1 H NMR spectra hexane extracts showed only two Nostoc genus accumulated...

10.1111/jpy.12959 article EN Journal of Phycology 2019-12-26

To determine the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in non-neoplastic patients with isolated intrathoracic lymphadenopathy (IL).This was a retrospective study IL referred for EBUS-TBNA. We calculated sensitivity, specificity, accuracy, positive predictive value (PPV), and negative (NPV) EBUS-TBNA diagnosis granulomatous, reactive, neoplastic lymphadenopathy. In cases nonspecific granulomas, reactive lymphadenopathy, or...

10.36416/1806-3756/e20180183 article EN cc-by-nc Jornal Brasileiro de Pneumologia 2020-01-01

Aims: To identify distinct asthma control clusters based on Control of Allergic Rhinitis and Asthma Test (CARAT) to compare patients’ characteristics among these clusters. Methods: Adults adolescents (≥13 years) with persistent were recruited at 29 Portuguese hospital outpatient clinics, in the context two observational studies INSPIRERS project. Demographic clinical characteristics, adherence inhaled medication, beliefs about anxiety depression, quality life, (CARAT, &gt;24 good control)...

10.32932/rpia.2020.12.046 article EN Revista Portuguesa de Imunoalergologia 2020-12-05

<b>Background:</b> Asthma is a heterogeneous disease with different severity degrees and several modifiable risk factors that might place the patient at for exacerbations. Their adequate management crucial to achieve control. When indicated, referral expert advice should be considered. <b>Aim:</b> Analyze characteristics of exacerbated asthmatics, namely their adverse outcomes, strategies follow-up. <b>Methods:</b> Retrospective study asthmatic patients admitted acute exacerbations in...

10.1183/13993003.congress-2016.pa4169 article EN 05.02 - Monitoring airway disease 2016-09-01

<b>Background:</b> Obesity-associated asthma is recognized as a distinct phenotype, but therapeutic options targeted to these patients are of uncertain efficacy. <b>Aim:</b> Assess the effect weight loss and biological therapies in control, quality life lung function obese asthmatics. <b>Methods:</b> Retrospective study asthmatic undergoing bariatric surgery (group 1) severe asthmatics on clinic 2), during 2016/2017. Asthma control (CARAT), (AQLQ) were assessed at baseline after 6-9 months...

10.1183/13993003.congress-2018.pa3691 article EN 2018-09-15

PR programs improve exercise capacity (EC) in patients (pts) with COPD and ILD, but few studies compare results between both diseases. The aim of this study was to evaluate the effect EC using 6-min walk test (6MWT) within ILD pts. Outcomes were change distance (6MWD) maximum heart rate (HRmax), comparison these changes groups according dyspnoea (modified medical research council scale - mMRC). pts mMRC ≥2 who completed an outpatient programme a Portuguese hospital during 2016...

10.1183/13993003.congress-2018.pa829 article EN 01.02 - Rehabilitation and chronic care 2018-09-15

The paper version of CARAT (pCARAT) is valid to assess asthma control over a 4-week period. For follow-up purposes, assessment through mobile apps (aCARAT) or telephone (tCARAT) may be useful alternatives. We explored the psychometric properties aCARAT and tCARAT. Patients with were recruited at secondary care outpatient clinics. During medical visits, patients filled in pCARAT invited complete following days using app project Inspirers (InspirerMundi). After 1 week, tCARAT was collected....

10.1183/13993003.congress-2019.pa741 article EN 2019-09-28

<sec> <title>BACKGROUND</title> Poor medication adherence is a major challenge in asthma, and objective assessment of inhaler needed. The InspirerMundi app aims to monitor while providing positive experience through gamification social support. </sec> <title>OBJECTIVE</title> This study aimed evaluate the feasibility acceptability adolescents adults with persistent asthma (treated daily inhaled medication). <title>METHODS</title> A 1-month mixed method multicenter observational was conducted...

10.2196/preprints.26442 preprint EN 2020-12-14

We aimed to explore which patients' characteristics were associated with a low engagement the InspirerMundi app. A 1-month multicenter observational study was conducted patients persistent asthma from 26 secondary care centers Portugal and Spain. During an initial in person visit, invited by their physician use app daily register medication intakes. Physicians reported whether it 1st or follow-up current treatment, number of exacerbations healthcare past year. Patients asked about...

10.1183/13993003.congress-2021.oa3947 article EN 2021-09-05
Coming Soon ...